Novonesis
Mikael A. Ludvigsen currently serves as the Chief Information Officer and Vice President at Novonesis since January 2024, emphasizing the importance of biosolutions. Prior to this role, Mikael held the position of CIO and Vice President at Novozymes from August 2016 to January 2024, contributing to advancements in biotechnology. Earlier experience includes serving as Group Vice President at DLG, where responsibilities encompassed membership in the Executive Steering Committee and the Board of Directors of GASA GROUP Holding A/S. Mikael's career also features leadership roles as CIO at Chr. Hansen and managerial positions at Novo Nordisk Engineering/NNE Pharmaplan, marked by significant achievements in IT operations and strategic management. Educational qualifications include a Master’s in Economics and Business Administration from Copenhagen Business School and a Board Certificate received in 2016.
This person is not in any offices
Novonesis
40 followers
At Novonesis, we believe solutions rooted in biology are key to tackling the challenges our world faces. Enzymes, functional proteins and microorganisms are our planet's tiniest, yet mightiest agents of change. When we leverage their power with science, we create biosolutions that transform the way we all produce, consume and live. Today, we are 10,000 people worldwide whose expertise spans more than 30 different industries. All around the world our biosolutions already create value for thousands of customers and benefit the planet. Our solutions enable feeding and fueling the world more sustainably, from healthy and sustainable nutrition to biofuel. Biosolutions also reduce the use of fossil-based resources, chemicals, energy and water. And this is just the beginning. The potential is almost endless. The time for biosolutions is now. And by working closely with our partners and customers, we will continue to challenge conventional thinking and transform business with biology. Together, we will create the change our world needs. Let’s better our world with biology.